Author

John Charles Riches

Observed names: J. Riches, John C Riches, John C. Riches, John Riches, Riches J, Riches, John C, Riches, John C., Riches,John C

Institutions: Queen Mary University of London, Barts Cancer Institute

Observed institutions: University of London, St Bartholomew's Hospital, Imperial College Healthcare NHS Trust, Queen Mary University of London, Barts Health NHS Trust, The Francis Crick Institute, Cancer Research UK, Hammersmith Hospital, John Radcliffe Hospital, Barts Cancer Institute, Imperial College London

ORCID: 0000-0002-3425-7686

Observed ORCID: 0000-0002-3425-7686

OpenAlex ID: A5001047632

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

2020 · Abi Vijenthira, Inna Y. Gong, et al. · Blood · 624

PDF

Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

2013 · Abasi Ene–Obong, Andrew J. Clear, et al. · Gastroenterology · 577

PDF

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production

2012 · John C. Riches, Jeffrey K. Davies, et al. · Blood · 529

PDF

Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics

2021 · Hamish W. King, Nara Orban, et al. · Science Immunology · 263

Mechanisms of PD-L1/PD-1–mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eµ-TCL1 CLL mouse model

2015 · Fabienne McClanahan, John C. Riches, et al. · Blood · 114

PDF

Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients

2020 · James A. Aries, Jeffrey K. Davies, et al. · British Journal of Haematology · 98

PDF

Understanding the Immunodeficiency in Chronic Lymphocytic Leukemia

2013 · John C. Riches, John G. Gribben · Hematology/Oncology Clinics of North America · 96

Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations

2014 · John C. Riches, Conor J. O’Donovan, et al. · Blood · 68

T-cell function in chronic lymphocytic leukaemia

2010 · John C. Riches, Alan G. Ramsay, et al. · Seminars in Cancer Biology · 57

Immunomodulation and Immune Reconstitution in Chronic Lymphocytic Leukemia

2014 · John C. Riches, John G. Gribben · Seminars in Hematology · 52

The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials

2021 · Jennyfa Kadiza Ali, John Charles Riches · Cancers · 46

PDF

Guideline for the treatment of chronic lymphocytic leukaemia

2022 · Renata Walewska, Nilima Parry‐Jones, et al. · British Journal of Haematology · 40

The Use of Breath Analysis in the Management of Lung Cancer: Is It Ready for Primetime?

2022 · Rachel J. Keogh, John C. Riches · Current Oncology · 39

PDF

Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies

2023 · Emma Searle, Francesco Forconi, et al. · Blood · 34

The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives

2023 · Toby A. Eyre, John C. Riches · Cancers · 28

PDF

Immune Reconstitution in Chronic Lymphocytic Leukemia

2012 · John C. Riches, Alan G. Ramsay, et al. · Current Hematologic Malignancy Reports · 28

Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy

2012 · John C. Riches, Alan G. Ramsay, et al. · Current Pharmaceutical Design · 26

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

2016 · John C. Riches, John G. Gribben · Current Cancer Drug Targets · 23

Chronic Lymphocytic Leukemia: An Update on Biology and Treatment

2011 · John C. Riches, Alan G. Ramsay, et al. · Current Oncology Reports · 21

Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients

2021 · Louise Caldwell, Anjaneya Bapat, et al. · Clinical Infectious Diseases · 19

PDF

Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper

2021 · Toby A. Eyre, John C. Riches, et al. · British Journal of Haematology · 17

PDF

Impact of COVID-19 in patients with lymphoid malignancies

2021 · John Charles Riches · World Journal of Virology · 17

PDF

Immunotherapeutic strategies including transplantation: eradication of disease

2013 · John G. Gribben, John C. Riches · Hematology · 16

Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy

2022 · Katarina Kluckova, Annalisa D’Avola, et al. · Cancers · 15

PDF

B-cell Receptor Signaling Induced Metabolic Alterations in Chronic Lymphocytic Leukemia Can Be Partially Bypassed by TP53 Abnormalities

2022 · Katarina Kluckova, Andrew J. Clear, et al. · HemaSphere · 15

Works count: 68

Citation count: 2,994

H-index: 20

I10-index: 30